SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...
Randomized double-blind phase II trial comparing gemcitabine (GEM) plus LY293111 vs. GEM plus placebo in advanced adenocarcinoma of the pancreas ...
Curcumin may help lower the levels of molecules that cause inflammation, such as cytokines and enzymes. This may help with arthritis, asthma, and inflammatory bowel disease. Curcumin may improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback